Alabama Medicaid and tirzepatide
Zepbound for weight loss: no. Preferred with clinical criteria for moderate to severe sleep apnea with obesity (BMI 30 or higher), age 18 or older, no diabetes. Mounjaro for weight loss: unclear; for type 2 diabetes Alabama Medicaid must cover it. Read from Alabama Medicaid Agency documents Nov 6, 2026.
Zepbound · Acentra Health for Alabama Medicaid Agency
“Zepbound is non-covered for weight reduction without OSA.”
read Nov 6, 2026
Zepbound · Alabama Medicaid Agency
“For OSA indications for incretin mimetics, patient must be ≥18 years of age with moderate to severe obstructive sleep apnea”
read Nov 6, 2026
In 2025 Alabama Medicaid paid for 19,804 tirzepatide prescriptions (Mounjaro, Zepbound), 28% of its GLP-1 prescriptions and 24th of the 50 states and DC. It reimbursed $20.5 million before rebates, $1,036 a prescription against $1,032 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Mounjaro | 18,761 | $19.4 million | $1,035 |
| Zepbound | 1,043 | $1.1 million | $1,061 |
Alabama plans and prescribing rules
Online prescribing. A September 2023 statement from the Alabama State Board of Medical Examiners says these medicines should be prescribed only in direct consultation with a licensed professional, and relays the Board of Pharmacy's ban on compounding with semaglutide salts or non-pharmaceutical-grade ingredients.
Tirzepatide in the states around Alabama
| State | Sell tirzepatide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Zepbound for weight loss |
|---|---|---|---|---|
| Alabama | 13 | $69/moWellmedr | 19,804 | Medicaid Zepbound: No |
| Florida | 17 | $69/moWellmedr | 15,477 | Medicaid Zepbound: Not covered (KFF) |
| Georgia | 16 | $69/moWellmedr | 8,964 | Medicaid Zepbound: Not covered (KFF) |
| Mississippi | 13 | $69/moWellmedr | 2,431 | Medicaid Zepbound: Yes |
| Tennessee | 16 | $69/moWellmedr | 44,570 | Medicaid Zepbound: Yes |



